Back
Pacira BioSciences Vs. Gilead Sciences Industry Stock Comparison
Sell
33
PCRX
Pacira BioSciences
Last Price:
14.50
Seasonality Move:
-2.82%
Buy
54
GILD
Gilead Sciences
Last Price:
83.95
Seasonality Move:
1.13%
Sell
33
Pacira BioSciences (PCRX)
is a Sell
Is Pacira BioSciences a Buy, Sell or Hold?
- The current Pacira BioSciences [PCRX] share price is $14.52. The Score for PCRX is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
- PCRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
54
Gilead Sciences (GILD)
is a Buy
Is Gilead Sciences a Buy, Sell or Hold?
- The current Gilead Sciences [GILD] share price is $83.94. The Score for GILD is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- GILD is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PCRX Stock Price Chart
What is Pacira BioSciences's stock price today?
-
The Pacira BioSciences share price today is $14.52
The current trend is relatively stagnant and PCRX is experiencing selling pressure, which indicates risk of future bearish movement.
GILD Stock Price Chart
What is Gilead Sciences's stock price today?
-
The Gilead Sciences share price today is $83.94
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GILD is experiencing buying pressure, which is a positive indicator for future bullish movement.
PCRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.66 | Sell |
| Relative Strength Index (14 RSI): | 46.94 | Sell |
| Chaikin Money Flow: | -1701132 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.35 - 14.93) | Buy |
| Bollinger Bands (100): | (15.74 - 28.84) | Sell |
GILD Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.28 | Buy |
| Relative Strength Index (14 RSI): | 75.43 | Buy |
| Chaikin Money Flow: | 22594918 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (76.18 - 82.5) | Buy |
| Bollinger Bands (100): | (65.53 - 77.59) | Buy |
PCRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.81 | Buy |
| 20-day SMA: | 14.24 | Buy |
| 50-day SMA: | 16.6 | Sell |
| 200-day SMA: | 26.16 | Sell |
| 8-day EMA: | 14.17 | Buy |
| 20-day EMA: | 14.41 | Buy |
| 50-day EMA: | 16.86 | Sell |
| 200-day EMA: | 24.76 | Sell |
GILD Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 83.11 | Buy |
| 20-day SMA: | 80.48 | Buy |
| 50-day SMA: | 76.78 | Buy |
| 200-day SMA: | 73.59 | Buy |
| 8-day EMA: | 82.92 | Buy |
| 20-day EMA: | 80.74 | Buy |
| 50-day EMA: | 77.14 | Buy |
| 200-day EMA: | 73.96 | Buy |
Pacira BioSciences Earnings Growth & PCRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.02 per share, an increase this year of $0.11 per share, and an increase next year of $0.00 per share.
Gilead Sciences Earnings Growth & GILD Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.32 per share, an increase next quarter of $0.20 per share, a decrease this year of $2.96 per share, and an increase next year of $3.33 per share.
Pacira BioSciences Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Gilead Sciences Technical Analysis
| Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||